Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Acute Lymphoblastic Leukemia
52%
Adolescence
19%
Biological Marker
24%
Body Mass Index
27%
Bone Cancer
22%
Bone Metastasis
33%
Cancer Surgery
45%
Chemotherapy
70%
Childhood Cancer
67%
Clinical Trial
27%
Cohort Analysis
40%
Colorectal Carcinoma
39%
Cumulative Incidence
47%
Diseases
47%
Distant Metastasis
24%
Event Free Survival
44%
Ewing Sarcoma
20%
Ganglioneuroblastoma
49%
Hazard Ratio
38%
Hip Replacement
28%
Implant
25%
Knee
27%
Malignant Neoplasm
35%
Median Follow Up
20%
Meta-Analysis
58%
Minimal Residual Disease
25%
Neoplasm
31%
Oncology
25%
Osteoarthritis
20%
Osteosarcoma
56%
Overall Survival
91%
Pediatrics
54%
Pediatrics Patient
19%
Prediction Model
31%
Prevalence
21%
Prognostic Factor
38%
Proportional Hazards Model
28%
Prospective Cohort Study
19%
Quality of Life
52%
Radiation Therapy
45%
Radiostereometric Analysis
20%
Randomized Controlled Trial
34%
Recurrent Disease
42%
Retrospective Cohort Study
26%
Retrospective Study
32%
Soft Tissue Sarcoma
93%
Systematic Review
64%
Total Hip Arthroplasty
28%
Total Knee Arthroplasty
25%
Tumor
40%
Keyphrases
5-year Survival
22%
95% Confidence Interval
98%
Acute Lymphoblastic Leukemia
59%
Chemotherapy
43%
Children with Cancer
26%
Clinical Outcomes
27%
Clinical Trials
23%
Colorectal Cancer Surgery
39%
Competing Risks
28%
Cox Model
25%
Cumulative Incidence
46%
Distant Metastasis
30%
Dutch
93%
Event-free Survival
51%
Ewing Sarcoma
19%
Extremity Soft Tissue Sarcoma
35%
Hazard Ratio
38%
Health-related Quality of Life
35%
High Risk
44%
High-risk Neuroblastoma
26%
Knee
22%
Local Recurrence
36%
Meta-analysis
91%
Minimal Residual Disease
27%
Multistate Model
32%
Netherlands
33%
Neuroblastoma
46%
Odds Ratio
26%
Oncological Outcomes
19%
Osteosarcoma
58%
Overall Survival
100%
Pediatric Acute Lymphoblastic Leukemia
23%
Pediatric Cancer Patients
28%
Pediatric Patients
26%
Postoperative Radiotherapy
19%
Prognostic Factors
51%
Quality of Life
25%
Radiotherapy
37%
Randomized Controlled Trial
43%
Retrospective Analysis
24%
Retrospective Cohort Study
24%
Risk Factors
57%
Risk Model
30%
Soft Tissue Sarcoma
49%
Survival Analysis
21%
Survival Outcomes
21%
Total Hip Arthroplasty
24%
Total Hip Replacement
22%
Tumor
32%
Working Diagnosis
36%